期刊文献+

转染Akt基因对心肌细胞I/R损伤的机制探讨

Experimental study of protective effect of cationic liposome mediated transfecting human Akt gene into cardiac myocytes against ischemia/reperfusion in vitro
下载PDF
导出
摘要 目的探讨转染基因Akt对心肌细胞缺血/再灌注(I/R)损伤的机制。方法采用新生SD大鼠进行心肌细胞培养,建立模拟心肌I/R模型;提取人Akt质粒,用阳离子脂质体介导的基因转染法将人Akt质粒转染心肌细胞。实验分5组:空白对照组(Control组)、缺血/再灌注损伤对照组(I/R组)、转染Akt基因组(Akt组)、转染阳离子脂质体空载体组(Vehicle control组)和Akt抑制剂组(Akt blockade组);各组进行I/R后测定乳酸脱氢酶(LDH)活性、四唑盐比色法检测细胞活性、免疫印迹法(Western blot法)检测细胞内Akt、低氧诱导因子-1α(hypoxia-inducible factor-1α,HIF-1α)蛋白表达。结果 Akt组较I/R组、Ve-hicle control组和Akt blockade组其LDH含量明显减少(P<0.05),细胞活性高(P<0.05),Akt与HIF-1α蛋白表达增加(P<0.05)。结论转染Akt基因可减少缺血性心脏病心肌细胞I/R损伤,对缺血性心脏病具有保护作用。 Objective To explore the effect and mechanism of transfecting human Akt gene against ischemia/reperfusion(I/R) in cardiac myocytes in vitro.Methods Cardiac myocytes from new born Sprague-Dawley rats were isolated and cultured in vitro and were randomly divided into five groups:control group,ischemia/ reperfusion(I/R)group,Akt group,vehicle control group and Akt blockade group.The levels of lactate dehydrogenase(LDH)and the cell activity in the medium were tested.The expression levels of Akt,HIF-1α protein were measured by Western blot.Results In comparison with I/R group,Vehicle control group and Akt blockade group,the levels of LDH in Akt group were significantly decreased(P0.05),together with higher cell activity(P0.05)with the highest protein expression levels of Akt and HIF-1αwere found by western blot(P0.05).Conclusion Transfecting plasmid Akt gene reduces injury in cultured cardiomyocytes against I/R and shows protection effects on ischemic heart disease.
出处 《重庆医学》 CAS CSCD 北大核心 2011年第23期2338-2340,2348,共4页 Chongqing medicine
关键词 蛋白质丝氨酸苏氨酸激酶 心肌 心肌再灌注损伤 protein-serine-threonine myocardium myocardial reperfusion injury
  • 相关文献

参考文献3

二级参考文献19

  • 1Semenza GL. Angiogenesis in ischemic and neoplastic disorders [J].Annu Rev Med, 2003, 54: 17-28.
  • 2Grines CL, Watkins MW, Helmer G, et al. Angiogenic gene therapy(AGENT) trial in patients with stable angina pectoris [J].Circulation, 2002, 105: 1291-7.
  • 3Sehwarz ER. Evaluation of the effects of intramyoeardial injection of DNA expressing vascular endothelial growth factor (VEGF) in a myocardial infarction model in the rot-angiogenesis and angioma formation[J]. J Am Coil Cardiol, 2000, 35: 1323-30.
  • 4Masaki I. Angiogenic gene therapy for experimental critical limb ischemia: over expression of vascular endothelial acceleration of limb loss by growth factor 165 but not of fibroblast growth factor-2[J]. Circ Res, 2002, 90: 966-73.
  • 5Fam NP, Verma S, Kutryk M, et al. Clinician guide to angiogenesis[J]. Circulation, 2003, 108(21): 2613-8.
  • 6Thurston G, Suri C, Smith K, et al. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1 [J]. Science,1999, 286:2511-4.
  • 7Lee JW, Bae SH, Jeong JW, et al. Hypoxia-inducible factor (HIF-1) alpha: its protein stability and biological functions [J]. Exp Mol Med, 2004, 36(1): 1-12.
  • 8Min JH, Yang H, Ivan M, et al. Structure of an HIF-1 alpha-pVHL complex: hydroxyproline recognition in signaling [J]. Science,2002, 296(5574): 1886-9.
  • 9Ivan M, Kondo K, Yang H, et al. HIFalpha targeted for VHLmediated destruction by proline hydroxylation: implications for O2 sensing[J]. Science, 2001, 292(5516): 464-8.
  • 10Masson N, Willam C, Maxwell PH, et al. Independent function of two destruction domains in hypoxia-inducible factor-alpha chains activated by prolyl hydroxylation [J]. EMBO J, 2001, 20 (18):5197-206.

共引文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部